IM Cannabis Corp. SEC filings IMCC
IM Cannabis Corp. has 302 filings in SEC EDGAR's recent list, going back to Oct 24, 2019. Its latest annual report, Form 20-F, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 20, 2026 | — |
| EFFECT | Filing | Jun 16, 2026 | — |
| CORRESP | Letter to the SEC | Jun 15, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2026 | — |
| EFFECT | Filing | Feb 11, 2026 | — |
| CORRESP | Letter to the SEC | Feb 9, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2026 | — |
| EFFECT | Filing | Aug 27, 2025 | — |
| CORRESP | Letter to the SEC | Aug 25, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| EFFECT | Filing | Jul 9, 2025 | — |
| CORRESP | Letter to the SEC | Jul 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2025 | — |
| D | Filing | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2022 | — |
| CORRESP | Letter to the SEC | May 19, 2022 | — |
| UPLOAD | Letter from the SEC | May 9, 2022 | — |
| SUPPL | Form suppl | May 6, 2021 | — |
| SUPPL | Form suppl | May 5, 2021 | — |
| EFFECT | Filing | Mar 31, 2021 | — |
| SEC STAFF ACTION | Filing | Feb 26, 2021 | — |
| CORRESP | Letter to the SEC | Feb 24, 2021 | — |
| CERT | Filing | Feb 24, 2021 | — |
| 40FR12B | Form 40fr12b | Feb 12, 2021 | — |
| D | Filing | Jul 9, 2020 | — |
| D | Filing | Jul 9, 2020 | — |
| D | Filing | Oct 24, 2019 | — |
| D | Filing | Oct 24, 2019 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- IMCC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Central District, Israel
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1792030
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.